EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prophylactic use of Levofloxacin during induction of acute lymphoblastic leukaemia in children—experience from Pakistan

Palwasha Rehman, Zunaira Shaukat, Haleema Saeed, Aun Raza, Sadia Anjum, Rabia Muhammad Wali

Journal of the Pakistan Medical Association · 2023

DOI: 10.47391/jpma.7383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pakistan Medical Association, 2023. Verfasst von Palwasha Rehman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To assess whether prophylactic use of Levofloxacin would reduce the number of febrile neutropenia episodes during the induction phase, a single-centre, case-control study was carried out. Data was collected prospectively of patients who received Levofloxacin prophylaxis during the induction chemotherapy from September 2019 till October 2020. The cases were compared with historical controls who did not receive antibiotics prophylaxis. A total of 121 patients were enrolled, among which 61 patients were cases, whereas 60 patients were controls. The patients who received Levofloxacin prophylaxis had lower rate of febrile neutropenia episodes than patients who did not receive any prophylaxis (P 0.01) (odds ratio [OR] :0.23, CI 95percent). No significant difference in induction mortality was seen between the two groups (p 0.14). Levofloxacin prophylaxis reduced the rate of febrile neutropenia episodes among patients, but it did not affect the infection related mortality. Keywords: Antibiotic Prophylaxis, Acute Lymphoblastic Leukaemia, Children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor Cell Lymphoblastic Leukemia-LymphomaFebrile NeutropeniaHumansChildLevofloxacinAnti-Bacterial AgentsCase-Control StudiesPakistanAntibiotic Prophylaxis

Stichwörter der Autor:innen

Antibiotic Prophylaxis, Acute Lymphoblastic Leukaemia, Children.

Substanzen

LevofloxacinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pediatric Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.
  • Department of Infectious Disease, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.

Zitieren

APA

Rehman, P., Shaukat, Z., Saeed, H., Raza, A., Anjum, S., & Wali, R. M. (2023). Prophylactic use of Levofloxacin during induction of acute lymphoblastic leukaemia in children—experience from Pakistan. Journal of the Pakistan Medical Association. https://doi.org/10.47391/jpma.7383

Vancouver

Rehman P, Shaukat Z, Saeed H, Raza A, Anjum S, Wali RM. Prophylactic use of Levofloxacin during induction of acute lymphoblastic leukaemia in children—experience from Pakistan. Journal of the Pakistan Medical Association. 2023. doi:10.47391/jpma.7383

BibTeX
@article{Rehman2023,
  author = {Rehman, Palwasha and Shaukat, Zunaira and Saeed, Haleema and Raza, Aun and Anjum, Sadia and Wali, Rabia Muhammad},
  title = {Prophylactic use of Levofloxacin during induction of acute lymphoblastic leukaemia in children—experience from Pakistan},
  journal = {Journal of the Pakistan Medical Association},
  year = {2023},
  doi = {10.47391/jpma.7383}
}
Kostenlos starten →